A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, ...

Columnist Oluwatosin Adesoye explains why preventing malaria infections is particularly important for those with sickle cell ...

Researchers evaluated the use of ultrawide field swept-source OCT-A to evaluate retinal vasculature in patients with sickle cell retinopathy.

Because sickle cell anemia symptoms can begin by four months of age, early diagnosis is critical. All newborns in the United States are now tested for the disease. Sickle cell anemia can be identified ...

Children with sickle cell disease, a chronic hemolytic anemia, present with a wide variety of neurological syndromes, including ischemic and hemorrhagic stroke, transient ischemic attacks ...

Background: The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously showed that daily oral HU reduces painful sickle cell (SS) crises by 50% in patients with moderate to ...

The center supports individuals living with thalassemia and sickle cell disease by delivering a holistic, patient-centric, and evidence-based model of care ABU DHABI: Under the patronage and in the ...

such as sickle cell anemia. But the severity of sickle cell disease can vary greatly from one patient to another because of a range of factors. Not all sickle cell patients will have the same physical ...

HILLSBOROUGH COUNTY, Fla. — There is an incredible story of love and sacrifice out of Plant City that helped to heal a little girl from sickle cell disease. Aliyah Reid spent the first five ...

Scedamin is a pediatric formulation of hydroxyurea being developed by Yunigen Inc. Scedamin is a pediatric formulation of hydroxyurea designed to treat children aged nine months and older who are ...